Weiran Feng, Hanzhi Luo, Qing Chen join Fox Chase Cancer Center as assistant professors

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

On Jan. 21, President Donald Trump announced the launch of the Stargate Project, a $500 billion artificial intelligence infrastructure project designed to revolutionize healthcare.

January 24, 2025

Vol.51 No.03

By Sorena Nadaf-Rahrov

In Brief

Janet Woodcock, Paul Kim join Friends’ board of directors

Janet WoodcockPaul T. KimJanet Woodcock, former director of the Center for Drug Evaluation and Research at FDA, and Paul T. Kim, principal of Kendall Square Policy Strategies LLC, were appointed to the board of directors at Friends of Cancer Research.

January 24, 2025

Vol.51 No.03

In Brief

University Hospitals and Case Western Reserve fund magnetic resonance fingerprinting research

The Collaborative Science Pilot Awards, a program supported by the Case Western Reserve University—University Hospitals Joint Strategic Leadership Committee, awarded five research teams $50,000 with the possibility of receiving additional funding as scientific milestones are met.

January 24, 2025

Vol.51 No.03

Clinical Roundup

Deadly dog cancer reveals clues for improved treatment, UF study finds

Researchers at the University of Florida College of Veterinary Medicine and the UF Health Cancer Center have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.

January 24, 2025

Vol.51 No.03

In Brief

Roland Dunbrack appointed co-leader of Cancer Signaling and Microenvironment Research Program at Fox Chase

Roland Dunbrack was named co-leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center alongside the program’s current leader, Edna Cukierman.

January 17, 2025

Vol.51 No.02

In Brief

Wistar’s Nan Zhang and Noam Auslander receive $1.2M in biomedical research grants from V Foundation

Nan ZhangNoam AuslanderNan Zhang and Noam Auslander, the Wistar Institute assistant professors, have both received independent funding totaling $1.2 million over the next three years for cancer research projects from the V Foundation for Cancer Research. The grants are awarded to cancer researchers deemed “V Scholars” and allow Zhang and Auslander to pursue separate projects aimed at new strategies to improve the effectiveness of certain cancer therapies.

December 13, 2024

Vol.50 No.46

Weiran Feng, Hanzhi Luo, Qing Chen join Fox Chase Cancer Center as assistant professors

YOU MAY BE INTERESTED IN

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

Janet Woodcock, Paul Kim join Friends’ board of directors

University Hospitals and Case Western Reserve fund magnetic resonance fingerprinting research

Deadly dog cancer reveals clues for improved treatment, UF study finds

Roland Dunbrack appointed co-leader of Cancer Signaling and Microenvironment Research Program at Fox Chase

Wistar’s Nan Zhang and Noam Auslander receive $1.2M in biomedical research grants from V Foundation

Renew today!

Subscriber content

Never miss an issue!

Login